Clinical Trial Update: Taxoprexin® Treatment for Advanced Eye Melanoma [Phase 2]

View source ↗

Summary

Phase 2 trial update reports completion of Taxoprexin studies for advanced eye melanoma; the excerpt does not include efficacy or safety results.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Melanoma
• Uveal Melanoma

Drugs mentioned

• Taxoprexin

Snippet

Sponsor: American Regent, Inc. | Conditions: Metastatic Melanoma | Phase 2 | Status: COMPLETED